HealthReveal, a NYC-based healthcare technology company that anticipates and mitigates adverse medical events for individuals with chronic disease, received an additional $500k in Series A funding.
With the strategic investment by Northwell Ventures, the round now totals $11.3m. The $10.8m Series A round, led by GE Ventures and joined by Greycroft Partners and Flare Capital Partners, was announced earlier in February 2017.
Led by Dr. Lonny Reisman, CEO and founder, HealthReveal partners with providers, payers and employers to guide patients to preempt life-threatening occurrences. To this end, the company has developed a cloud-based, decision support solution that analyzes the health of at-risk patients in real time. By using evidence-based medicine and providing continual monitoring as a foundation for machine learning, health risks are detected and proactively addressed to avoid costly utilization and permanent adverse health outcomes.